Walgreens Boots Alliance (NASDAQ:WBA) Given New $19.00 Price Target at Barclays

Walgreens Boots Alliance (NASDAQ:WBA) had its price target trimmed by Barclays from $21.00 to $19.00 in a research report sent to investors on Monday, Benzinga reports. The brokerage currently has an underweight rating on the pharmacy operator’s stock.

A number of other analysts also recently weighed in on the company. SVB Leerink cut their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a market perform rating for the company in a research report on Monday, March 18th. Raymond James reiterated a market perform rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. UBS Group dropped their target price on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a neutral rating for the company in a research report on Wednesday, April 3rd. Leerink Partnrs reiterated a market perform rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Finally, Bank of America lowered their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an underperform rating for the company in a research report on Tuesday, March 26th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of Hold and an average target price of $23.07.

Walgreens Boots Alliance Stock Performance

WBA opened at $15.91 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The company has a market capitalization of $13.73 billion, a PE ratio of -2.27, a price-to-earnings-growth ratio of 0.99 and a beta of 0.78. The business has a fifty day simple moving average of $16.80 and a 200 day simple moving average of $20.41. Walgreens Boots Alliance has a 1 year low of $14.62 and a 1 year high of $31.88.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. Walgreens Boots Alliance’s revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.16 earnings per share. Research analysts expect that Walgreens Boots Alliance will post 3.21 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 6.29%. The ex-dividend date was Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -14.29%.

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The shares were bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Highlander Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at $26,000. Pineridge Advisors LLC bought a new stake in Walgreens Boots Alliance in the fourth quarter valued at $26,000. Venturi Wealth Management LLC raised its holdings in shares of Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 981 shares during the period. Rocky Mountain Advisers LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter worth about $30,000. Finally, Quest Partners LLC acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at about $30,000. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.